GlassScriptPhysician profile
Frank A Sirchia
NPI 1467564252
$3,468.85
in general payments reported to CMS, 2019-2025
36 companies · $720 in 2025
The $720 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,100 · 2020: $188 · 2021: $428 · 2022: $270 · 2023: $443 · 2024: $320 · 2025: $720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,482.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $385.57 | 2019-2025 | |
| Amarin Pharma, INC. | $385.11 | 2019-2021 | |
| Exact Sciences Corporation | $382.92 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $292.98 | 2019-2025 | Airsupra, Farxiga |
| Novo Nordisk INC | $277.83 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $170.46 | 2022-2025 | Kisunla, Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $149.78 | 2021-2022 | |
| Amgen INC. | $147.45 | 2019-2025 | Repatha, Repatha, Otezla |
| Merck Sharp & Dohme LLC | $140.82 | 2019-2025 | Gardasil 9, Capvaxive |
| Sanofi-Aventis U.S. LLC | $119.24 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.31 | 2019-2025 | Jardiance |
| Astellas Pharma US INC | $86.26 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $85.54 | 2019-2025 | Zoryve, Seglentis, Livalo |
| Lucid Diagnostics INC. | $71.18 | 2023 | |
| Allergan, INC. | $60.23 | 2019-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $58.11 | 2021 | |
| Novartis Pharmaceuticals Corporation | $49.59 | 2022 | |
| Eisai INC. | $46.69 | 2021 | |
| Medtronic, INC. | $43.38 | 2025 | Intellis Adaptivestim |
| Boston Scientific Corporation | $39.09 | 2023-2025 | General - Pain Management, Watchman Flx |
| Janssen Pharmaceuticals, INC | $35.54 | 2019-2020 | |
| Itamar Medical INC | $34.70 | 2025 | Watchpatone |
| Abbvie INC. | $28.82 | 2021 | |
| Insmed, INC. | $27.86 | 2025 | Brinsupri |
| Hologic Sales and Service, LLC | $25.31 | 2023 | Aptima, Thinprep 2000 Processor, Third Wave |
| Dexcom, INC. | $23.70 | 2025 | Dexcom G6 Transmitter |
| Watermark Medical, INC. | $23.22 | 2023 | Ares Home Sleep Testing Device |
| Si-Bone, INC. | $23.17 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $23.00 | 2021 | |
| Sanofi Pasteur INC. | $20.69 | 2019 | |
| Abbott Laboratories | $20.35 | 2024 | Freestyle Libre 3 |
| Nabriva Therapeutics, Plc | $19.22 | 2021 | |
| Stryker Corporation | $19.15 | 2025 | Clottriever Bold Catheter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.53 | 2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $18.37 | 2020 | |
| Metuchen Pharmaceuticals | $15.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Sirchia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.